MoneyConsumerRecalls

Actions

RECALL: Blood pressure medications with trace amounts of carcinogen

Posted: 5:54 AM, Mar 19, 2019
Updated: 2019-03-19 09:54:35Z
Losartan-BP+med+recall+March+15.JPG

WASHINGTON DC — More blood pressure medication is being recalled for trace amounts of a carcinogen.

Forty repackaged lots of Losartan Tablets USP 25mg, 50mg, and 100mg were voluntarily recalled on March 15.

The recall is due to detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid, a possible process impurity or contaminant in an active pharmaceutical ingredient, which is manufactured by Hetero Labs Limited, according to the U.S. Food and Drug Administration.

For more information on this recall, click here [fda.gov] .

Three lots of Losartan Tablets USP 50mg also were voluntarily recalled on March 15.

Losartan Potassium USP is used to treat high blood pressure and congestive heart failure. It is packaged in 30-count bottles.

"This recall was prompted due to Torrent Pharmaceuticals LTD issuing a Voluntary Nationwide Recall of Losartan Tablets, USP, due to the detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited," according to the FDA.

Pharmacies nationwide distribute the medications.

For more information about the recall, click here [fda.gov]